| AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial |
Globe Newswire |
06/25 |
16:00 |
| MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer |
Globe Newswire |
06/25 |
16:00 |
| Recce Pharmaceuticals Receives Ethics Approval to Broaden RECCE® 327 Gel Trials Across all Topical Bacterial Skin Infections |
Globe Newswire |
06/25 |
16:00 |
| Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film |
Globe Newswire |
06/25 |
16:00 |
| LOBO EV Strengthens Partnership with a Well-Established Brazilian Distributor Following Successful On-Site Inspection |
Globe Newswire |
06/25 |
16:00 |
| Tyton Partners Paying for Choice 2024 Research Finds That Education Savings Accounts (ESAs) Can Help 14% More K-12 Parents Afford Private School |
Globe Newswire |
06/25 |
16:00 |
| Tyton Partners’ Choose to Learn 2024 Research Reveals Massive Untapped Demand for K-12 Parent Navigation Supports |
Globe Newswire |
06/25 |
16:00 |
| Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024 |
Globe Newswire |
06/25 |
16:00 |
| Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24 |
Globe Newswire |
06/25 |
16:00 |
| Lightbridge Welcomes Passage of the ADVANCE Act, Landmark Legislation to Expedite Commercial Deployment of Advanced Nuclear Fuel and Other Advanced Nuclear Technologies |
Globe Newswire |
06/25 |
16:00 |
| 8 Rivers Appoints Asheley Kinsey as New Chief Financial Officer |
Globe Newswire |
06/25 |
16:00 |
| Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer |
Globe Newswire |
06/25 |
16:00 |
| GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease |
Globe Newswire |
06/25 |
16:00 |
| Asset Entities Golf Consultant and Shareholder Bryson DeChambeau Wins U.S. Open |
Globe Newswire |
06/25 |
16:00 |
| BioVie Presents Protocol Design of Upcoming SUNRISE-PD Phase 2 Trial of Bezisterim in Patients with Early Parkinson’s Disease at ATMRD 2024 |
Globe Newswire |
06/25 |
16:00 |
| Immutep Signs Exclusive License Agreement with Cardiff University for Next Generation Anti-LAG-3 Molecules for Cancer |
Globe Newswire |
06/25 |
16:00 |
| Apogee Minerals Announces Geophysical Work at The Pine Channel and Shasko Bay Projects, Saskatchewan |
Globe Newswire |
06/25 |
16:00 |
| Greenwood Racing Inc. Acquires The Inn at Fox Chase |
Globe Newswire |
06/25 |
16:00 |
| Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers |
Globe Newswire |
06/25 |
16:00 |
| AI in Healthcare Market is Forecasted to grow at a CAGR of 48.1% Over the Period of 2024-2029 |
Globe Newswire |
06/25 |
16:00 |
| Humacyte Presents Positive Preclinical Data For Its BioVascular Pancreas (BVP™) Program |
Globe Newswire |
06/25 |
16:00 |
| Pacific Green enters Polish energy storage market with double acquisition |
Globe Newswire |
06/25 |
16:00 |
| Huntress CEO Kyle Hanslovan Wins Coveted EY’s 2024 Entrepreneur Of The Year® Award for the Mid-Atlantic |
Globe Newswire |
06/25 |
16:00 |
| Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Advanced TNBC |
Globe Newswire |
06/25 |
15:43 |
| Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial |
Globe Newswire |
06/25 |
15:30 |
